Genex Pharmaceutical Stock Today
| GENX Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 13
|
Genex Pharmaceutical is trading at 1.0E-4 as of the 25th of April 2024; that is No Change since the beginning of the trading day. The stock's open price was 1.0E-4. Genex Pharmaceutical has less than a 13 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Genex Pharmaceutical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft in the Peoples Republic of China. Genex Pharmaceutical is headquartered in Tianjin City, the Peoples Republic of China. Genex Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. The company has 0 outstanding shares. More on Genex Pharmaceutical
Moving together with Genex Pink Sheet
| 1.0 | LPCUF | Lees Pharmaceutical | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Genex Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Genex Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Genex Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Sina Pirooz |
| Old Name | Generix |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Genex Pharmaceutical [GENX] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Nano-Cap' category with a current market capitalization of 110.64 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genex Pharmaceutical's market, we take the total number of its shares issued and multiply it by Genex Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Genex Pharmaceutical conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 0 outstanding shares.
Genex Pharmaceutical currently holds about 430.12 K in cash with 529.66 K of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Genex Pharmaceutical Probability Of Bankruptcy
Genex Stock Against Markets
Picking the right benchmark for Genex Pharmaceutical pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Genex Pharmaceutical pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Genex Pharmaceutical is critical whether you are bullish or bearish towards Genex Pharmaceutical at a given time. Please also check how Genex Pharmaceutical's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Genex Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Genex Pharmaceutical Corporate Directors
Genex Pharmaceutical corporate directors refer to members of a Genex Pharmaceutical board of directors. The board of directors generally takes responsibility for the Genex Pharmaceutical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Genex Pharmaceutical's board members must vote for the resolution. The Genex Pharmaceutical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| William Xiong | Independent Director | Profile | |
| Philippe Seguin | Director of the Industrial Division and Member of the Management Board | Profile | |
| Conny Lin | Director | Profile | |
| Jamie Lewin | CFO, Director | Profile |
How to buy Genex Pink Sheet?
Before investing in Genex Pharmaceutical, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Genex Pharmaceutical. To buy Genex Pharmaceutical stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Genex Pharmaceutical. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Genex Pharmaceutical stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Genex Pharmaceutical stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Genex Pharmaceutical stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Genex Pharmaceutical, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Genex Pharmaceutical?
The danger of trading Genex Pharmaceutical is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Genex Pharmaceutical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Genex Pharmaceutical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Genex Pharmaceutical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genex Pharmaceutical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Genex Pink Sheet analysis
When running Genex Pharmaceutical's price analysis, check to measure Genex Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genex Pharmaceutical is operating at the current time. Most of Genex Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Genex Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genex Pharmaceutical's price. Additionally, you may evaluate how the addition of Genex Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |